4 from Medicine receive Duke REACH Equity funding awards
Three Department of Medicine faculty and one trainee have received funding from the Duke Center for Research to Advance Health Equity.
Faculty promotions from January through June 2018
Congratulations to the following Department of Medicine faculty who received promotions in the first half of 2018.
Divisions select faculty recipients for 2018 Excellence in Education Awards
The recipients of the Department of Medicine faculty Excellence in Education Awards have been announced.
Duke Global Cancer Request for Applications - Pilot Projects
Duke Global Health Institute and Cancer Institute will provide up to $25,000 direct costs for one year of support for each pilot research project that address issues relating to cancer prevention, diagnosis, or treatment in resource constrained environments. Two pilot projects will be funded. Deadline is July 16, 2018.
DeVito receives Damon Runyon Cancer Research Foundation Physician-Scientist Training Award
Nicholas C. DeVito, MD, fellow in Hematology-Oncology, has received one of five Physician-Scientist Training Awards from the Damon Runyon Cancer Research Foundation.
Duke research on patient-related outcomes in cancer care is honored by Springer Nature journals
A journal article by Thomas LeBlanc, MD, associate professor of medicine (Hematologic Malignancies and Cellular Therapy), and Amy Abernethy, MD, adjunct professor of medicine (Medical Oncology), has been recognized as a paper that could "Change the World, One Article At A Time" by Springer Nature journals.
5/17/18: Clinical Research Day at Duke
Registration is open for the School of Medicine's Clinical Research Day from 4-7:30 p.m. on May 17 in the Great Hall of the Trent Semans Center.
3/23/18: NCI director to present at Medicine Grand Rounds
Ned Sharpless, MD, director of the National Cancer Institute, will present at Medicine Grand Rounds on Fri., March 23 at 8 a.m. in Duke North Room 2002.
7 from Medicine selected for LEADER program
7 faculty from the Department of Medicine will participate in the School of Medicine's LEADER program.
A search to disrupt cancer-cell trickery that makes malignant cells seem harmless
These are heady days for immunotherapy researchers, the scientists making progress unleashing the human immune system against lethal cancers.
Interventions once envisioned in laboratories are now treatments saving the lives of some patients struck by melanoma, kidney cancer, and lung cancer. Promise is rising for treatments against malignancies arising elsewhere as well.
With his new insights into how cancer cells use biochemical signaling to suppress our immune system, Brent Hanks, MD, PhD, is part of this translational momentum.